EUVIMEDEUVIMED entdecken
Open Access

Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer

Lauren E Himmel, Maryam B Lustberg, A Courtney DeVries, Ming Poi, Ching-Shih Chen, Samuel K Kulp

Experimental and Toxicologic Pathology · 2016-10 · 68 (9) · 505-515

DOI: 10.1016/j.etp.2016.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Toxicologic Pathology, 2016-10. Verfasst von Lauren E Himmel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA; Division of Medicinal Chemi…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAnimalsAntineoplastic Combined Chemotherapy ProtocolsApoptosisBlotting, WesternCell Line, TumorCell SurvivalCognition DisordersCyclophosphamideDNA DamageDoxorubicinFemaleHumansImmunohistochemistryMiceMice, NudeMinocyclineNeuroprotective AgentsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Chemo fogChemotherapyChemotherapy-induced cognitive impairmentMinocyclineTriple-negative breast cancer

Substanzen

Neuroprotective AgentsDoxorubicinCyclophosphamideMinocycline

Autor:innen und Institutionen

  • Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University…
  • Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
  • Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Electronic address: kulp.1@osu.edu.

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Himmel, L. E., Lustberg, M. B., DeVries, A. C., Poi, M., Chen, C. S., & Kulp, S. K. (2016). Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology, 68(9), 505-515. https://doi.org/10.1016/j.etp.2016.08.001

Vancouver

Himmel LE, Lustberg MB, DeVries AC, Poi M, Chen CS, Kulp SK. Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology. 2016;68(9):505-515. doi:10.1016/j.etp.2016.08.001

BibTeX
@article{Himmel2016,
  author = {Himmel, Lauren E and Lustberg, Maryam B and DeVries, A Courtney and Poi, Ming and Chen, Ching-Shih and Kulp, Samuel K},
  title = {Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer},
  journal = {Experimental and Toxicologic Pathology},
  year = {2016},
  volume = {68},
  number = {9},
  pages = {505--515},
  doi = {10.1016/j.etp.2016.08.001}
}
Kostenlos starten →